| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |